Bharat Parenterals Ltd Fair Value
BPLPHARMA · Healthcare · Current price ₹1,436.4
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹324 | -13% ROE fading to 13% over ~3 yrs, on ₹468 book |
| Relative P/E | ₹498 | EPS × 34.7 peer-median P/E |
| Graham floor | ₹388 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Bharat Parenterals Ltd undervalued?
DocStoX estimates the fair value of Bharat Parenterals Ltd at ₹383 per share, versus the current market price of ₹1,436. That puts the stock about -73.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹324), Relative P/E (₹498), Graham floor (₹388). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹324 (bear) to ₹383 (base) to ₹498 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Bharat Parenterals Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.